🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested
Rhesus conflict between mother and fetus is due to the different antigenic ...
Status
Unknown
Location
Municipal non-profit enterprise "Cherkasy Regional Hospital of Cherkasy Regional Council"
Start Date
2022-02-08
Trial ID
NCT05245734
Treatments Being Tested
Pneumonia is the most common infection in intensive care unit (ICU) patient...
Status
Completed
Location
Royal Brisbane and Women's Hospital
Start Date
2019-10-17
Trial ID
NCT04986254
Critically ill patients with flu may receive a drug called oseltamivir. The...
Status
Completed
Location
University of Michigan Hospital
Start Date
2009-10
Trial ID
NCT01048879
Treatments Being Tested
Nelfinavir will increase the efficacy of Cisplatin based chemo- radiation t...
Status
Completed
Location
University of Miami
Start Date
2012-01
Trial ID
NCT01485731
The purpose of this study is to determine whether it is possible to predict...
Status
Terminated
Location
Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Start Date
2011-05
Trial ID
NCT01855061
Treatments Being Tested
Talaromycosis continues to be a common opportunistic fungal infection among...
Status
Unknown
Location
Chiang Mai University Hospital
Start Date
2019-06-01
Trial ID
NCT04031053
Treatments Being Tested
During an In Vitro Fertilization (IVF) attempt, several embryos are obtaine...
Status
Completed
Location
CHU Toulouse
Start Date
2021-12-07
Trial ID
NCT05109676
Treatments Being Tested
Endoscopic retrograde cholangiopancreatography (ERCP) comes with a risk for...
Status
Recruiting
Location
RadboudUMC
Start Date
2022-03-01
Trial ID
NCT05267379
Treatments Being Tested
This is a Phase I, open-label, 2-part study in patients with a confirmed di...
Status
Completed
Location
Research Site
Start Date
2014-12-22
Trial ID
NCT02197234